SavedAdd your journal

Journals / Ulusal Travma Dergisi / 2003 / Cilt: 9 - Sayı: 3

Symmetrical peripheral gangrene and dopamine

Taner ÇOLAK
Okan ERDOĞAN
Özlem YEREBAKAN
Cumhur ARICI
Alihan GÜRKAN
Pages
222–224
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Care should be taken with the use of dopamine in patients with shock.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We describe the case of a 55-year-old man with hypovolemic shock who developed a symmetrical peripheral gangrene (SPG) on hands and feet.
📊
Key Findings & Data:In this case, dopamine was used with high dose (> 20 µg/kg/min) which is inappropriate in hypovolemic shock states.
💡
Conclusion & Impact:Care should be taken with the use of dopamine in patients with shock.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kan nakli · El parmakları · Gastrointestinal kanama

Abstract

We describe the case of a 55-year-old man with hypovolemic shock who developed a symmetrical peripheral gangrene (SPG) on hands and feet. The SPG syndrome consists of sudden onset of symmetrical gangrene of the fingers, toes and rarely, the nose, upper lip, ear lobes or genitals without large vessel obstruction or vasculitis. Vasopressors have been implicated directly or as a contributory cause in many cases. In this case, dopamine was used with high dose (> 20 µg/kg/min) which is inappropriate in hypovolemic shock states. SPG might be a severe and rare complication of dopamine. Care should be taken with the use of dopamine in patients with shock.

🔖

Cite This Article

ÇOLAK, T., ERDOĞAN, O., YEREBAKAN, Ö., ARICI, C., GÜRKAN, A. (2003). Symmetrical peripheral gangrene and dopamine. Ulusal Travma Dergisi, Cilt: 9 - Sayı: 3, 222–224. https://ajindex.com/articles/324974

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Hutchinson J. Severe symmetrical gangrene of the extremities. Br Med J. 1891; 2: 8-9
  2. Cotton RT, Bedford DR. Symmetric peripheral gangrene complicating acute myocardial infarction. Am J Med. 1956; 20: 301-307
  3. Abrahams DG. Incipient symmetrical peripheral gangrene complicating paroxysmal tachycardia. Br Heart J. 1948; 10: 191-194
  4. Joheansen K, Hansen ST Jr. Symmetrical peripheral gangrene (purpura fulminans) complicating pneumococcal sepsis. Am J Surg. 1993; 165: 642-645
  5. Itin P, Stalder H, Vischer W. Symmetrical peripheral gangrene in disseminated tuberculosis. Dermatologica. 1986; 173: 189-195
  6. Arrowsmith JE, Woodhead MA, Bevan DH, et al. Digital gangrene in small cell lung cancer: response to aspirin treatment. Thorax. 1991; 46: 63-64
  7. Molos MA, Hall JC. Symmetrical peripheral gangrene and disseminated intravascular coagulation. Arch Dermatol.1985; 121: 1057-1061
  8. Davis MDP, Byrd J, Lior T, et al. Symmetrical peripheral gangrene due to disseminated intravascular coagulation. Arch Dermatol. 2001; 137: 139-140
  9. Joynt G, Doedens L, Lipman J, et al. High-dose adrenaline with low systemic vascular resistance and symmetrical peripheral gangrene. S Afr J Surg. 1996; 34: 99-101
  10. Hayes MA, Yau EH, Hinds CJ, Watson JD. Symmetrical peripheral gangrene: association with noradrenalin administration. Intensive Care Med. 1992; 18: 433-436
  11. Nichol J, Girling F, Jerrard W, et al. Fundamental instability of the small blood vessels and critical closing pressures in vascular beds. Am J Physiol. 1951; 164: 330-334
  12. Roddie IC, Shepherd JT. Evidence for critical closure of digital resistance vessels with reduced transmural pressure and passive dilatation with increased venous pressure. J Physiol. 1957; 136: 498-506. 13.Stetson JB, Reading GP. Avoidance of vascular complications associated with the use of dopamine. Can Anaesth Soc J. 1977; 24: 727-733
  13. Winkler MJ, Trunkey DD. Dopamine gangrene. Association with disseminated intravascular coagulation. Am J Surg. 1981; 142: 588-591
  14. Alexander C, Sako Y, Mikulic E. Pedal gangrene associated with the use of dopamine. N Engl J Med. 1975; 293: 591
  15. Barriere SL, Hudson LD, Huseby JS. Gangrene and dopamine. Ann Intern Med. 1977; 86: 366-367
  16. Park JY, Kanzler M, Swetter SM. Dopamine-associated symmetrical peripheral gangrene. Arch Dermatol. 1997; 133: 247-249
  17. Denning DW, Gilliland L, Hewlett A, et al. Peripheral symmetrical gangrene successfully treated with epoprostenol and t